-+ 0.00%
-+ 0.00%
-+ 0.00%
Imattix Biomedicine announced that research results related to its PRAME tumor antigen pipeline will be presented at the 2026 European Society of Medical Oncology Conference.
Share
Listen to the news
Imattix Biomedicine announced that research results related to its PRAME tumor antigen pipeline will be presented at the 2026 European Society of Medical Oncology Conference.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending